|
DDAH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.16573417585641E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.30693242286861E-12 |
| Normal-vs-Stage2 |
1.52829999999771E-06 |
| Normal-vs-Stage3 |
3.23140003644085E-09 |
| Normal-vs-Stage4 |
3.51769999995533E-06 |
| Stage1-vs-Stage2 |
5.696600E-01 |
| Stage1-vs-Stage3 |
8.399200E-01 |
| Stage1-vs-Stage4 |
3.600000E-01 |
| Stage2-vs-Stage3 |
5.281000E-01 |
| Stage2-vs-Stage4 |
2.504800E-01 |
| Stage3-vs-Stage4 |
4.860600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.0242700545009E-12 |
| Normal-vs-AfricanAmerican |
1.89046999999887E-05 |
| Normal-vs-Asian |
1.65219999903599E-08 |
| Caucasian-vs-AfricanAmerican |
1.739610E-02 |
| Caucasian-vs-Asian |
5.914400E-01 |
| AfricanAmerican-vs-Asian |
1.215820E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.0819999885523E-09 |
| Normal-vs-Female |
7.83817455385361E-14 |
| Male-vs-Female |
3.897400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.53863596810788E-12 |
| Normal-vs-Age(41-60Yrs) |
6.95843382914063E-12 |
| Normal-vs-Age(61-80Yrs) |
9.59289999657997E-08 |
| Normal-vs-Age(81-100Yrs) |
2.768000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.613600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.532210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.483600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.404800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.291600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.156400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.516100E-02 |
| Classical-VS-Follicular |
2.451200E-01 |
| Classical-VS-Other |
2.915200E-01 |
| Classical-VS-Normal |
1.63369318073592E-12 |
| Tall-VS-Follicular |
4.448000E-01 |
| Tall-VS-Other |
7.426200E-01 |
| Tall-VS-Normal |
6.44459999999958E-05 |
| Follicular-VS-Other |
5.324800E-01 |
| Follicular-VS-Normal |
7.86460000457012E-08 |
| Other-VS-Normal |
2.464600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.75639955304996E-10 |
| Normal-vs-N1 |
7.55789999999923E-05 |
| N0-vs-N1 |
6.095600E-01 |
|
|
